Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
Immune Therapeutics, Inc. Signs Binding Letter of Intent to Collaborate with Cytocom, Inc. to Develop Lodonal(TM) and Other Drugs for COVID-19; Other Drug Development Programs Also Moving Forward ...
ORLANDO, March 01, 2023 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTC Pink: IMUN) ("Immune" or "IMUN"), a specialty pharmaceutical company involved in the acquisition, development and ...
‘Imun I-Park Xi,’ the largest complex developed in Imun and Hwikyung New Town, received nearly 5,000 applications in its non-designated subscription. It is evaluated that the high expectations of ...
Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results